GeneDx Holdings Corp. (WGS) shareholders
Close on Nov 17, 2026Market cap $1.41BP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Keith A. Meister Joint filing with Corvex Management LP (16.10%), Eli Casdin (13.70%) and 3 more | 5,356,767 | 17.90% | 13D (active) amendment | May 20, 2026 |
| Meister, Keith A. Joint filing with Corvex Management LP (16.10%), Eli Casdin (12.00%) and 3 more | 5,356,767 | 17.90% | 13D (active) amendment | May 14, 2026 |
| Casdin Eli Joint filing with Casdin Partners GP, LLC (12.40%), Casdin Capital, LLC (12.30%) and 3 more | 4,096,095 | 14.20% | 13D (active) amendment | May 5, 2025 |
| FMR LLC Joint filing with Abigail P. Johnson (10.00%) | 2,793,953 | 10.00% | 13G (passive) | Mar 31, 2025 |
| The Goldman Sachs Group, Inc. Joint filing with Goldman Sachs & Co. LLC (5.80%) | 1,733,592 | 5.80% | 13G (passive) | Jun 30, 2026 |
| BlackRock, Inc. | 1,622,518 | 5.50% | 13G (passive) | Jun 30, 2026 |
| Catherine D. Wood Joint filing with ARK Investment Management LLC (5.33%) | 1,581,810 | 5.33% | 13G (passive) amendment | Jul 31, 2026 |
| William Blair Investment Management, LLC | 1,560,247 | 5.20% | 13G (passive) | Sep 30, 2026 |
| Matthew Curtis Joint filing with Summit Partners Public Asset Management, LLC (5.19%), Philip Furse (5.19%) and 2 more | 1,426,968 | 5.19% | 13G (passive) | Feb 5, 2025 |
| Goldman Sachs & Co. LLC Joint filing with The Goldman Sachs Group, Inc. (5.20%) | 1,421,903 | 5.20% | 13G (passive) | Dec 31, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of WGS | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Corvex Management LP | 4,784,570 | 16.04% | $328.46M | +1,556,421 | 10.03% |
| Casdin Capital, LLC | 3,707,164 | 12.43% | $254.50M | +700,000 | 12.74% |
| BlackRock, Inc. | 1,706,239 | 5.72% | $117.13M | +155,531 | 0.00% |
| Goldman Sachs Group Inc | 1,669,441 | 5.60% | $114.61M | +334,461 | 0.01% |
| ARK Investment Management LLC | 1,610,189 | 5.40% | $110.54M | +285,606 | 0.72% |
| William Blair Investment Management, LLC | 1,400,653 | 4.70% | $96.15M | +625,384 | 0.29% |
| Morgan Stanley | 988,297 | 3.31% | $67.85M | +456,062 | 0.00% |
| Vanguard Capital Management LLC | 879,003 | 2.95% | $60.34M | +20,420 | 0.00% |
| Citadel Advisors LLC | 865,462 | 2.90% | $59.41M | +218,061 | 0.01% |
| First Light Asset Management, LLC | 783,923 | 2.63% | $53.82M | +540,996 | 3.27% |
| Deep Track Capital, LP | 700,000 | 2.35% | $48.06M | New | 0.70% |
| Nikko Asset Management Americas, Inc. | 666,581 | 2.24% | $45.70M | +27,781 | 0.59% |
| Sumitomo Mitsui Trust Holdings, Inc. | 666,581 | 2.24% | $45.76M | +33,124 | 0.03% |
| Assenagon Asset Management S.A. | 606,866 | 2.03% | $41.66M | +511,738 | 0.03% |
| Zweig-DiMenna Associates LLC | 571,950 | 1.92% | $39.26M | −117,340 | 3.56% |
| Geode Capital Management, LLC | 552,125 | 1.85% | $37.91M | +2,978 | 0.00% |
| State Street Corp | 527,815 | 1.77% | $36.23M | +55,370 | 0.00% |
| Gagnon Securities LLC | 524,865 | 1.76% | $36.03M | +221,716 | 6.94% |
| abrdn plc | 457,201 | 1.53% | $31.39M | +227,105 | 0.04% |
| Wellington Management Group Llp | 347,927 | 1.17% | $23.89M | +6,922 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 223 | 32M | 100.0% | 56 / 85 | 58 / 70 | 9M | 9M |
| Q1 2026 | 240 | 31M | 100.0% | 42 / 100 | 72 / 84 | 8M | 6M |
| Q4 2025 | 287 | 31M | 100.0% | 59 / 94 | 101 / 37 | 4M | 3M |
| Q3 2025 | 268 | 30M | 100.0% | 69 / 86 | 82 / 31 | 4M | 6M |
| Q2 2025 | 231 | 32M | 100.0% | 55 / 88 | 62 / 48 | 9M | 6M |
| Q1 2025 | 225 | 28M | 95.3% | 59 / 85 | 59 / 31 | 8M | 3M |
| Q4 2024 | 199 | 24M | 78.9% | 83 / 70 | 32 / 18 | 8M | 3M |
| Q3 2024 | 136 | 19M | 63.3% | 57 / 42 | 23 / 6 | 5M | 1M |
| Q2 2024 | 86 | 16M | 54.6% | 40 / 24 | 11 / 12 | 5M | 4M |
| Q1 2024 | 58 | 15M | 52.0% | 19 / 16 | 8 / 9 | 3M | 1M |
| Q4 2023 | 48 | 13M | 44.3% | 10 / 9 | 14 / 12 | 4M | 4M |
| Q3 2023 | 53 | 14M | 46.8% | 5 / 17 | 15 / 10 | 0M | 1M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
307 funds held WGS in Q1 2026, 30% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of WGS | Value | % of fund | As of |
|---|---|---|---|---|---|
| ARK Innovation ETF | 876,607 | 2.94% | $57.08M | 1.03% | Jul 31, 2026 |
| Vanguard Total Stock Market Index Fund | 607,773 | 2.04% | $41.72M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 523,338 | 1.75% | $35.93M | 0.04% | Jun 30, 2026 |
| ARK Genomic Revolution ETF | 446,965 | 1.50% | $29.10M | 1.87% | Jul 31, 2026 |
| Eventide Gilead Fund | 266,042 | 0.89% | $18.26M | 0.53% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 249,890 | 0.84% | $17.15M | 0.02% | Jun 30, 2026 |
| Strategic Advisers U.S. Total Stock Fund | 222,516 | 0.75% | $11.57M | 0.01% | May 31, 2026 |
| Fidelity Small Cap Index Fund | 218,876 | 0.73% | $14.25M | 0.04% | Jul 31, 2026 |
| Franklin Small Cap Growth Fund | 201,666 | 0.68% | $13.13M | 0.53% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 184,614 | 0.62% | $12.67M | 0.08% | Jun 30, 2026 |
| Alger Small Cap Focus Fund | 130,474 | 0.44% | $8.50M | 1.00% | Jul 31, 2026 |
| William Blair Small-Mid Cap Growth Fund | 126,588 | 0.42% | $8.69M | 0.66% | Jun 30, 2026 |
| William Blair Small Cap Growth Fund | 125,324 | 0.42% | $8.60M | 0.70% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 110,973 | 0.37% | $5.77M | 0.01% | May 31, 2026 |
| Schwab U.S. Small-Cap ETF | 103,149 | 0.35% | $5.36M | 0.02% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Katherine Stueland | CHIEF EXECUTIVE OFFICER, Director | 115,476 | 0.39% | Sep 18, 2026 |
| Kevin Feeley | CHIEF FINANCIAL OFFICER | 48,035 | 0.16% | Sep 18, 2026 |
| Mark A. Gardner | President | – | – | Jul 1, 2026 |
| Bryan Dechairo | Chief Operating Officer | 2,723 | 0.01% | Mar 5, 2026 |
| Thomas Fuchs | Director | 1,146 | 0.00% | Sep 18, 2026 |
| Emily M. Leproust | Director | 24,852 | 0.08% | Jun 23, 2026 |
| Keith A. Meister | Director, 10% owner | 4,808,275 | 16.12% | Jun 23, 2026 |
| Joshua Ruch | Director | 189,566 | 0.64% | Jun 23, 2026 |
| Richard C. Pfenniger Jr | Director | 45,082 | 0.15% | Jun 23, 2026 |
| Eli Casdin | Director, 10% owner | 4,083,648 | 13.69% | Jun 23, 2026 |
| Jason Ryan | Director | 118,764 | 0.40% | Jun 23, 2026 |
| Casdin Partners GP, LLC | Director, 10% owner | – | – | Jun 8, 2026 |
| Casdin Partners Master Fund, L.P. | Director, 10% owner | 3,880,072 | 13.01% | Jun 8, 2026 |
| Casdin Capital, LLC | Director, 10% owner | 3,859,555 | 12.94% | Jun 8, 2026 |
| Management LP Corvex | Director, 10% owner | 3,374,334 | 11.31% | May 15, 2026 |
| Mount Sinai Health System, Inc. | 10% owner | 123,176,901 | 413.03% | Nov 19, 2024 |
| School Of Medicine At Mount Sinai Icahn | 10% owner | 2,719,692 | 9.12% | Nov 19, 2024 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Thomas Fuchs Director | Sep 17, 2026 | Option exercise | +1,146 | – | – | 1,146 |
| Kevin Feeley CHIEF FINANCIAL OFFICER | Sep 16, 2026 | Sale | −52 | $95.41 | $4.96K | 48,035 |
| Kevin Feeley CHIEF FINANCIAL OFFICER | Sep 16, 2026 | Sale | −1,470 | $98.27 | $144.46K | 46,024 |
| Kevin Feeley CHIEF FINANCIAL OFFICER | Sep 16, 2026 | Sale | −541 | $96.90 | $52.42K | 47,494 |
| Kevin Feeley CHIEF FINANCIAL OFFICER | Sep 16, 2026 | Sale | −1,079 | $99.00 | $106.82K | 44,945 |
| Kevin Feeley CHIEF FINANCIAL OFFICER | Sep 16, 2026 | Sale | −586 | $94.26 | $55.24K | 48,087 |
| Kevin Feeley CHIEF FINANCIAL OFFICER | Sep 16, 2026 | Option exercise | +7,197 | – | – | 48,673 |
| Katherine Stueland CHIEF EXECUTIVE OFFICER, Director | Sep 16, 2026 | Sale | −3,039 | $99.00 | $300.86K | 115,476 |
| Katherine Stueland CHIEF EXECUTIVE OFFICER, Director | Sep 16, 2026 | Option exercise | +18,750 | – | – | 125,977 |
| Katherine Stueland CHIEF EXECUTIVE OFFICER, Director | Sep 16, 2026 | Sale | −1,648 | $94.26 | $155.34K | 124,329 |
| Katherine Stueland CHIEF EXECUTIVE OFFICER, Director | Sep 16, 2026 | Sale | −148 | $95.41 | $14.12K | 124,181 |
| Katherine Stueland CHIEF EXECUTIVE OFFICER, Director | Sep 16, 2026 | Sale | −1,525 | $96.90 | $147.77K | 122,656 |
| Katherine Stueland CHIEF EXECUTIVE OFFICER, Director | Sep 16, 2026 | Sale | −4,141 | $98.27 | $406.94K | 118,515 |
| Katherine Stueland CHIEF EXECUTIVE OFFICER, Director | Sep 9, 2026 | Sale | −3,692 | $84.22 | $310.94K | 107,227 |
| Katherine Stueland CHIEF EXECUTIVE OFFICER, Director | Sep 9, 2026 | Option exercise | +6,547 | – | – | 110,919 |
| Kevin Feeley CHIEF FINANCIAL OFFICER | Sep 9, 2026 | Sale | −1,285 | $84.22 | $108.22K | 41,476 |
| Kevin Feeley CHIEF FINANCIAL OFFICER | Sep 9, 2026 | Option exercise | +2,462 | – | – | 42,761 |
| Kevin Feeley CHIEF FINANCIAL OFFICER | Sep 1, 2026 | Option exercise | +717 | – | – | 40,671 |
| Kevin Feeley CHIEF FINANCIAL OFFICER | Sep 1, 2026 | Sale | −372 | $83.84 | $31.19K | 40,299 |
| Jason Ryan Director | Jun 18, 2026 | Option exercise | +3,576 | – | – | 15,480 |
| Richard C. Pfenniger Jr Director | Jun 18, 2026 | Option exercise | +3,576 | – | – | 45,082 |
| Joshua Ruch Director | Jun 18, 2026 | Option exercise | +3,576 | – | – | 33,299 |
| Keith A. Meister Director, 10% owner | Jun 18, 2026 | Option exercise | +3,576 | – | – | 23,705 |
| Eli Casdin Director, 10% owner | Jun 18, 2026 | Option exercise | +3,576 | – | – | 24,093 |
| Emily M. Leproust Director | Jun 18, 2026 | Option exercise | +3,576 | – | – | 24,852 |
| Katherine Stueland CHIEF EXECUTIVE OFFICER, Director | Jun 16, 2026 | Sale | −2,429 | $61.50 | $149.38K | 104,372 |
| Katherine Stueland CHIEF EXECUTIVE OFFICER, Director | Jun 16, 2026 | Option exercise | +18,750 | – | – | 114,873 |
| Katherine Stueland CHIEF EXECUTIVE OFFICER, Director | Jun 16, 2026 | Sale | −2,140 | $59.75 | $127.87K | 112,733 |
| Katherine Stueland CHIEF EXECUTIVE OFFICER, Director | Jun 16, 2026 | Sale | −5,932 | $60.83 | $360.84K | 106,801 |
| Kevin Feeley CHIEF FINANCIAL OFFICER | Jun 16, 2026 | Sale | −760 | $59.75 | $45.41K | 42,923 |
| Kevin Feeley CHIEF FINANCIAL OFFICER | Jun 16, 2026 | Option exercise | +7,197 | – | – | 43,683 |
| Kevin Feeley CHIEF FINANCIAL OFFICER | Jun 16, 2026 | Sale | −863 | $61.50 | $53.07K | 39,954 |
| Kevin Feeley CHIEF FINANCIAL OFFICER | Jun 16, 2026 | Sale | −2,106 | $60.83 | $128.11K | 40,817 |
| Katherine Stueland CHIEF EXECUTIVE OFFICER, Director | Jun 9, 2026 | Option exercise | +6,546 | – | – | 99,762 |
| Katherine Stueland CHIEF EXECUTIVE OFFICER, Director | Jun 9, 2026 | Sale | −3,639 | $53.77 | $195.67K | 96,123 |
| Kevin Feeley CHIEF FINANCIAL OFFICER | Jun 9, 2026 | Sale | −1,266 | $53.77 | $68.07K | 36,486 |
| Kevin Feeley CHIEF FINANCIAL OFFICER | Jun 9, 2026 | Option exercise | +2,462 | – | – | 37,752 |
| Eli Casdin Director, 10% owner | Jun 5, 2026 | Buy | +50,000 | $52.86 | $2.64M | 3,707,164 |
| Eli Casdin Director, 10% owner | Jun 4, 2026 | Buy | +150,000 | $56.44 | $8.47M | 3,657,164 |
| Kevin Feeley CHIEF FINANCIAL OFFICER | Jun 1, 2026 | Sale | −369 | $51.74 | $19.09K | 35,290 |
| Kevin Feeley CHIEF FINANCIAL OFFICER | Jun 1, 2026 | Option exercise | +717 | – | – | 35,659 |
| Casdin Partners Master Fund, L.P. Director, 10% owner | May 20, 2026 | Buy | +140,000 | $43.81 | $6.13M | 3,507,164 |
| Casdin Partners Master Fund, L.P. Director, 10% owner | May 19, 2026 | Buy | +185,000 | $42.60 | $7.88M | 3,367,164 |
| Casdin Partners Master Fund, L.P. Director, 10% owner | May 18, 2026 | Buy | +175,000 | $42.55 | $7.45M | 3,182,164 |
| Keith A. Meister Director, 10% owner | May 15, 2026 | Buy | +27,408 | $38.28 | $1.05M | 4,765,705 |
| Keith A. Meister Director, 10% owner | May 15, 2026 | Buy | +18,865 | $39.83 | $751.39K | 4,784,570 |
| Keith A. Meister Director, 10% owner | May 14, 2026 | Buy | +88,107 | $39.08 | $3.44M | 4,686,404 |
| Keith A. Meister Director, 10% owner | May 14, 2026 | Buy | +51,893 | $39.92 | $2.07M | 4,738,297 |
| Keith A. Meister Director, 10% owner | May 13, 2026 | Buy | +94,074 | $38.82 | $3.65M | 4,527,371 |
| Keith A. Meister Director, 10% owner | May 13, 2026 | Buy | +70,926 | $39.45 | $2.80M | 4,598,297 |
| Keith A. Meister Director, 10% owner | May 11, 2026 | Buy | +252,734 | $39.65 | $10.02M | 4,432,765 |
| Keith A. Meister Director, 10% owner | May 11, 2026 | Buy | +532 | $40.35 | $21.47K | 4,433,297 |
| Keith A. Meister Director, 10% owner | May 11, 2026 | Buy | +246,734 | $38.91 | $9.60M | 4,180,031 |
| Keith A. Meister Director, 10% owner | May 8, 2026 | Buy | +73,104 | $41.15 | $3.01M | 3,933,297 |
| Keith A. Meister Director, 10% owner | May 8, 2026 | Buy | +79,144 | $40.67 | $3.22M | 3,860,193 |
| Keith A. Meister Director, 10% owner | May 8, 2026 | Buy | +3,396 | $38.70 | $131.43K | 3,781,049 |
| Keith A. Meister Director, 10% owner | May 8, 2026 | Buy | +15,745 | $38.00 | $598.31K | 3,777,653 |
| Keith A. Meister Director, 10% owner | May 7, 2026 | Buy | +116,412 | $38.46 | $4.48M | 3,610,922 |
| Keith A. Meister Director, 10% owner | May 7, 2026 | Buy | +123,393 | $37.60 | $4.64M | 3,494,510 |
| Keith A. Meister Director, 10% owner | May 7, 2026 | Buy | +14,786 | $36.33 | $537.18K | 3,371,117 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of GeneDx's stock actually held short. Settlement fails (shares not delivered on time) peaked at 2,512 shares on Sep 21, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Katherine Stueland Officer, Director | Sep 1, 2026 | 14,243 | $1.21M | Sep 9, 2026 | Acquired as compensation - Restricted Stock Units |
| Kevin Feeley Officer | Sep 1, 2026 | 5,410 | $458.50K | Sep 1, 2026 | Acquired as compensation - Restricted Stock Units |
| Kevin Feeley Officer | Apr 29, 2026 | 5,804 | $366.00K | Apr 29, 2026 | Acquired as compensation - Restricted Stock Units |
| Katherine Stueland Director, Officer | Apr 29, 2026 | 16,415 | $1.04M | Apr 29, 2026 | Acquired as compensation - Restricted Stock Units |
| Bryan Dechairo Officer | Feb 2, 2026 | 9,374 | $929.90K | Feb 2, 2026 | Acquired as compensation - Restricted Stock Units |
| Katherine Stueland Officer, Director | Jan 29, 2026 | 94,495 | $9.27M | Jan 29, 2026 | Acquired as compensation - Restricted Stock Units |
| Kevin Feeley Officer | Jan 29, 2026 | 24,155 | $2.37M | Jan 29, 2026 | Acquired as compensation - Restricted Stock Units |
| Joshua Ruch Director | Nov 24, 2025 | 38,000 | $6.09M | Nov 24, 2025 | Restricted Stock Units |
| Kevin Feeley Officer | Sep 30, 2025 | 12,414 | $1.34M | Sep 30, 2025 | Acquired as compensation - Restricted Stock Units |
| Katherine Stueland Officer, Director | Sep 30, 2025 | 29,283 | $3.16M | Sep 30, 2025 | Acquired as compensation - Restricted Stock Units |
| Jason Ryan Director | Aug 27, 2025 | 39,222 | $4.99M | Aug 27, 2025 | Open market acquisition |
| Casdin Partners Master Fund, L.P. Affiliate | Aug 22, 2025 | 500,000 | $60.45M | Aug 22, 2025 | Purchase |
| Kevin Feeley Officer | Jul 1, 2025 | 12,427 | $1.15M | Jul 1, 2025 | Restricted Stock Unit Granted |
| Katherine Stueland Director, Officer | Jul 1, 2025 | 29,302 | $2.69M | Jul 1, 2025 | Restricted Stock Unit Granted |
| Katherine Stueland Officer, Director | Jun 9, 2025 | 14,139 | $1.03M | Jun 9, 2025 | Restricted Stock Unit Vest |
See a number that looks wrong?